HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Clinical trials for HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat breast cancer? first human trial underway
Disease control CompletedThis study tested a new drug called OP-1250 in 153 adults with advanced or metastatic hormone receptor-positive, HER2-negative breast cancer. The goal was to find the safest dose and see if the drug can shrink tumors. Participants had already tried at least one hormone therapy be…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Olema Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New program eases joint pain and helps breast cancer survivors stay on treatment
Symptom relief CompletedThis study tested a special pain program for breast cancer survivors who have joint and muscle pain caused by their hormone therapy (aromatase inhibitors). The program combined counseling, education, and coping strategies to help reduce pain, improve mood, and make it easier for …
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 02:02 UTC